ReShape Lifesciences, Inc.ReShape Lifesciences, Inc.ReShape Lifesciences, Inc.

ReShape Lifesciences, Inc.

No trades
See on Supercharts

RSLS fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, the Obalon Balloon System, and the Diabetes Bloc-Stim Neuromodulation device. The firm sells the Lap-Band worldwide and is managed in the following geographical regions: United States, Australia, Europe, and the Rest of World. The company was founded in December 2002 and is headquartered in Irvine, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
RSLS has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company